In patients with venous thromboembolism in association with COVID-19, laboratory tests indicate high levels of prothrombotic markers (fibrinogen and D-Dimer), and inflammatory markers (C reactive protein, IL-6), which are related to hypercoagulable state [46,47]. The gene discussed is IL6; the disease is COVID-19.